Neogene Therapeutics is now a part of the AstraZeneca Group. Visit AstraZeneca.com. AstraZeneca.com ...

%PDF-1.3 %Äåòåë§ó ÐÄÆ 3 0 obj /Filter /FlateDecode /Length 70917 >> stream x ̽k»$·qçù¾>EIT7«IöaeVÖ ÖH#Q¤lëbZ¤ÆòŠ3;R›ºŒy±DÉ—ýžû}ö÷ @f%*3«µ¶ôç «€@Ü# üaû÷Û?l÷ÛýS»ßï ‡vÛœ÷û§ËeÛ .üÜþñ³í?l¿Ü¾ûþ×ÍöÕ×ÛÆþÿõ+¾Â ší ñó ûóóøg6áçÅôŸo ·ý -:9åÆ@8 }…0% ¾Ü?5mw=Ÿ [ÍYü©I÷O§æxºœ üv>uçýñºÙ ...

Dr. Perez Garcia is the Vice President of Translational Sciences at Neogene Therapeutics. She has more than 16 years of combined academic and biopharma industry experience in cancer immunology and immunotherapy research supporting preclinical projects for engineered T cell therapies in oncology.

Neogene T-Cell Processing. Sign in with Neogene Sign in with AstraZeneca

Acquisition provides access to next-generation T-cell receptor therapies with promising potential for targeting solid tumors SANTA MONICA, Calif., and AMSTERDAM, November 28, 2022 – Neogene Therapeutics, Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and manufacturing of next-generation T ...

Neogene Therapeutics, Inc. 2225 Colorado Ave Santa Monica, CA 90404 United States

Neogene Therapeutics Raises $110 Million Series A Financing to Develop Next-Generation Fully Personalized Neo-Antigen T Cell Receptor (TCR) Therapies